Clinical Trials - Cognitive Issues and HIV
-
A5324: A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with No Intensification or Intensification with Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Study Location: Baltimore
Eligibility: Men and women > 18 years old who have HIV-associated neurocognitive disorder (HAND) as defined by the Frascati...
Enrollment: Open